Allspring Global Investments Holdings LLC bought a new position in Cognex Corporation (NASDAQ:CGNX - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 20,392 shares of the scientific and technical instruments company's stock, valued at approximately $753,000.
Several other hedge funds also recently made changes to their positions in the stock. Northwestern Mutual Wealth Management Co. grew its position in shares of Cognex by 12.9% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 2,132 shares of the scientific and technical instruments company's stock valued at $68,000 after purchasing an additional 243 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd grew its position in shares of Cognex by 1.8% in the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 14,611 shares of the scientific and technical instruments company's stock valued at $662,000 after purchasing an additional 256 shares in the last quarter. Arizona State Retirement System boosted its stake in Cognex by 0.6% during the third quarter. Arizona State Retirement System now owns 49,651 shares of the scientific and technical instruments company's stock valued at $2,249,000 after buying an additional 285 shares during the period. Public Employees Retirement System of Ohio boosted its stake in Cognex by 0.5% during the third quarter. Public Employees Retirement System of Ohio now owns 54,349 shares of the scientific and technical instruments company's stock valued at $2,462,000 after buying an additional 292 shares during the period. Finally, Centaurus Financial Inc. boosted its stake in Cognex by 8.1% during the second quarter. Centaurus Financial Inc. now owns 4,021 shares of the scientific and technical instruments company's stock valued at $128,000 after buying an additional 303 shares during the period. 88.12% of the stock is currently owned by hedge funds and other institutional investors.
Cognex Price Performance
CGNX opened at $53.41 on Friday. The business has a 50 day simple moving average of $50.64 and a two-hundred day simple moving average of $43.97. The firm has a market capitalization of $8.92 billion, a price-to-earnings ratio of 79.72 and a beta of 1.47. Cognex Corporation has a one year low of $22.84 and a one year high of $59.88.
Cognex (NASDAQ:CGNX - Get Free Report) last posted its earnings results on Wednesday, February 11th. The scientific and technical instruments company reported $0.27 earnings per share for the quarter, topping analysts' consensus estimates of $0.22 by $0.05. Cognex had a return on equity of 9.02% and a net margin of 11.51%.The firm had revenue of $252.34 million for the quarter, compared to the consensus estimate of $238.92 million. During the same quarter in the prior year, the business earned $0.16 EPS. The business's revenue for the quarter was up 9.9% on a year-over-year basis. As a group, sell-side analysts expect that Cognex Corporation will post 0.61 EPS for the current fiscal year.
Cognex Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Thursday, March 12th. Shareholders of record on Thursday, February 26th were issued a dividend of $0.085 per share. The ex-dividend date was Thursday, February 26th. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.6%. Cognex's dividend payout ratio is 50.75%.
Analyst Ratings Changes
Several research firms recently issued reports on CGNX. Weiss Ratings reissued a "hold (c)" rating on shares of Cognex in a research note on Monday, December 29th. TD Cowen reissued a "buy" rating on shares of Cognex in a research note on Tuesday, February 17th. The Goldman Sachs Group lifted their price objective on Cognex from $50.00 to $68.00 and gave the company a "buy" rating in a research note on Tuesday, February 17th. KeyCorp reissued an "overweight" rating and set a $70.00 price objective (up from $50.00) on shares of Cognex in a research note on Friday, February 13th. Finally, UBS Group reissued a "buy" rating and set a $70.00 price objective on shares of Cognex in a research note on Friday, February 13th. Two analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $57.00.
Get Our Latest Research Report on Cognex
Insiders Place Their Bets
In other Cognex news, Director Angelos Papadimitriou sold 4,150 shares of the company's stock in a transaction that occurred on Monday, February 23rd. The stock was sold at an average price of $55.58, for a total transaction of $230,657.00. Following the transaction, the director owned 16,222 shares in the company, valued at approximately $901,618.76. This represents a 20.37% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Robert Willett sold 177,052 shares of the company's stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $58.39, for a total value of $10,338,066.28. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 196,083 shares of company stock worth $11,419,321. Company insiders own 1.70% of the company's stock.
About Cognex
(
Free Report)
Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.
The company's product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cognex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognex wasn't on the list.
While Cognex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report